![](/img/cover-not-exists.png)
The novel suramin analogue NF864 selectively blocks P2X1receptors in human platelets with potency in the low nanomolar range
Susanne Horner, Kirsten Menke, Caren Hildebrandt, Matthias U. Kassack, Peter Nickel, Heiko Ullmann, Martyn P. Mahaut-Smith, Günter LambrechtVolume:
372
Language:
english
Pages:
13
DOI:
10.1007/s00210-005-1085-z
Date:
July, 2005
File:
PDF, 304 KB
english, 2005